Disconnecting the “self-destruct button” causing lung damage in flu
By Rob Clancy, staff writer. Reviewed by Associate Professor Michelle Tate
Influenza (flu) can be fatal, but just how it causes severe damage to the lungs has been a mystery….until now.
New research has identified a protein which acts as a “self-destruct button” in the lungs, opening the door to new treatments that fight the disease.
Influenza causes up to 650,000 deaths globally each year and severe flu can lead to hospitalisation, lung failure, and long-term health issues, but that’s not the worst of it, according to Associate Professor Michelle Tate.
She specialises in understanding how hyperinflammation develops in severe respiratory disease, and she warns that current treatment options are limited, and resistance to antiviral drugs is rising.
Reducing lung damage from flu
“Every year, thousands of people, especially adults 65+ and those with weakened immune system, get seriously ill from the flu,” A/Prof Tate said. “Our findings could lead to new medicines that reduce lung damage and inflammation, helping people recover faster and lowering the risk of death from severe flu.”
So, what are these findings, and why are they important?
Working with PhD Student, Sarah Rosli, A/Prof Tate uncovered a new way the body responds to the influenza virus.
“We found that a protein called Gasdermin E plays a major role in causing lung damage during influenza. By deleting this protein, we were able to reduce inflammation and improve survival,” she said.
“We discovered that Gasdermin E acts like a ‘self-destruct’ button in lung epithelial cells during infection, causing them to burst and release inflammatory signals.”
She said the actions of this protein lead to more tissue damage and worsen illness.
A pathway to less severe flu
“When we removed this protein, the lungs stayed healthier, and the flu was less severe. This opens up exciting possibilities for new treatments that help the body fight flu more effectively.”
This world-first study shows that a protein Gasdermin E is activated by multiple strains of the influenza virus and plays a central role in triggering epithelial cell death and uncontrolled inflammation.
“By blocking this pathway, we were able to reduce inflammation and viral replication, pointing to a new way to treat severe flu across different virus types,” Ms Rosli said.
This research is published in Cell Death & Disease.
Influenza facts
- Influenza (flu) is a contagious virus that spreads easily from person to person and infects the nose, throat and lungs.
- Influenza viruses spread easily from person to person through the air in droplets when someone with the flu coughs, sneezes or speaks.
- The first flu symptoms may appear like a common cold including a runny nose, sneezing and a sore throat. While a cold develops slowly, the flu is fast and includes fevers and aches.
- People can catch the flu anytime, but the virus spreads mostly during winter. In Australia, the peak flu season is generally April to October.
- The best protection against the flu, is prevention through annual vaccination. There are new strains for the flu each year, so a new vaccine is needed each year.
Journal | Cell Death & Disease
Title | Gasdermin E deficiency limits inflammation and lung damage during influenza virus infection
View publication | https://www.nature.com/articles/s41419-025-07748-0
In this article
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”